Effects of Transcranial Direct Current Stimulation (tDCS) and Motor Learning in Children With Cerebral Palsy (CP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01852474|
Recruitment Status : Completed
First Posted : May 13, 2013
Last Update Posted : March 21, 2017
|Condition or disease||Intervention/treatment||Phase|
|Cerebral Palsy||Device: Transcranial Direct Current Stimulation (tDCS)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||5 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effects of tDCS in Cortical Plasticity and Motor Learning in Children With Cerebral Palsy|
|Actual Study Start Date :||May 2013|
|Actual Primary Completion Date :||May 2016|
|Actual Study Completion Date :||May 2016|
Experimental: Active tDCS
Subjects will receive active tDCS stimulation for 5 sessions (20m/each) over one week.
Device: Transcranial Direct Current Stimulation (tDCS)
Subjects will receive tDCS stimulation 1x per day for 5 days (over the period of 1 week). Each session will be 20 minutes long. The subject will receive active stimulation for the entire 20 minutes.
- Changes in motor assessments [ Time Frame: Approximately 2 weeks ]Investigators will measure changes in kinematic (sensor) assessments from baseline to follow-up. The sensor will collect Inertial Measurements Units (IMU) and complex motion sensing, as measured by accelerometer/gyroscope/magnetometer of freedom motion capture.
- Changes in TMS measurements [ Time Frame: Approximately 2 weeks ]Investigators will measure change in TMS measurements from baseline to follow-up. TMS measures will consist of: motor threshold, motor evoked potentials (MEP's), transcallosal inhibition, and examinations of intracortical inhibition and facilitation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01852474
|United States, Massachusetts|
|Spaulding Rehabilitation Network Research Institute|
|Charlestown, Massachusetts, United States, 02129|
|Principal Investigator:||Felipe Fregni, MD PhD MPH||Spaulding Rehabilitation Hospital|